中国临床药理学杂志
中國臨床藥理學雜誌
중국림상약이학잡지
The Chinese Journal of Clinical Pharmacology
2015年
21期
2108-2110,2169
,共4页
米索前列醇%晚期妊娠%引产%不同剂量
米索前列醇%晚期妊娠%引產%不同劑量
미색전렬순%만기임신%인산%불동제량
misoprostol%late pregnancy%induced labor%different dosage
目的:通过不同剂量、不同时间的米索前列醇阴道给药,观察其在晚期妊娠引产中的临床疗效和安全性,探索米索前列醇阴道用药的剂量和方法。方法180例符合引产指征的足月妊娠妇女随机分为6组,其中5组分别阴道内放置米索前列醇引产,剂量和时间分别为12.5μg q6 h( A组),25μg q6 h( B组),25μg q12 h(C组),50μg q6 h(D组),50μg q12 h(E组),1组为对照组,静脉点滴催产素引产。结果 A组24,48 h引产成功率低于对照组,B、C、D、E组引产成功率均高于对照组(P<0.05),4组间差异无统计学意义(P>0.05)。 A、B、C、D、E组剖宫产率低于对照组,阴道分娩率高于对照组( P<0.05);B、C、D、E组产程显著短于对照组( P<0.01);B、C组引产48 h成功率差异无统计学意义(P>0.05)。结论25μgq6h米索前列醇引产成功率高,阴道分娩率高,剖宫产率低且宫缩过强,且不良反应发生率低,为临床值得推荐的剂量和方法。
目的:通過不同劑量、不同時間的米索前列醇陰道給藥,觀察其在晚期妊娠引產中的臨床療效和安全性,探索米索前列醇陰道用藥的劑量和方法。方法180例符閤引產指徵的足月妊娠婦女隨機分為6組,其中5組分彆陰道內放置米索前列醇引產,劑量和時間分彆為12.5μg q6 h( A組),25μg q6 h( B組),25μg q12 h(C組),50μg q6 h(D組),50μg q12 h(E組),1組為對照組,靜脈點滴催產素引產。結果 A組24,48 h引產成功率低于對照組,B、C、D、E組引產成功率均高于對照組(P<0.05),4組間差異無統計學意義(P>0.05)。 A、B、C、D、E組剖宮產率低于對照組,陰道分娩率高于對照組( P<0.05);B、C、D、E組產程顯著短于對照組( P<0.01);B、C組引產48 h成功率差異無統計學意義(P>0.05)。結論25μgq6h米索前列醇引產成功率高,陰道分娩率高,剖宮產率低且宮縮過彊,且不良反應髮生率低,為臨床值得推薦的劑量和方法。
목적:통과불동제량、불동시간적미색전렬순음도급약,관찰기재만기임신인산중적림상료효화안전성,탐색미색전렬순음도용약적제량화방법。방법180례부합인산지정적족월임신부녀수궤분위6조,기중5조분별음도내방치미색전렬순인산,제량화시간분별위12.5μg q6 h( A조),25μg q6 h( B조),25μg q12 h(C조),50μg q6 h(D조),50μg q12 h(E조),1조위대조조,정맥점적최산소인산。결과 A조24,48 h인산성공솔저우대조조,B、C、D、E조인산성공솔균고우대조조(P<0.05),4조간차이무통계학의의(P>0.05)。 A、B、C、D、E조부궁산솔저우대조조,음도분면솔고우대조조( P<0.05);B、C、D、E조산정현저단우대조조( P<0.01);B、C조인산48 h성공솔차이무통계학의의(P>0.05)。결론25μgq6h미색전렬순인산성공솔고,음도분면솔고,부궁산솔저차궁축과강,차불량반응발생솔저,위림상치득추천적제량화방법。
Objective To observe the clinical effect and safety of miso-prostol in the treatment of induced labor of late pregnancy by different dosage and different time through vaginal delivery, and explore the dos-age and method of misoprostol vaginal delivery.Methods A total of 180 cases in induced labor indications of full term pregnant women were ran-domly divided into six groups, including five groups for medicines, re-spectively using vaginal placing misoprostol in induced labor, dosage and time were 12.5 μg q6 h ( A group ) , 25 μg q6 h ( B group ) , 25 μg q12 h ( C group) , 50μg q6 h ( D group) , 50μg q12 h ( E group) , an-other group of intravenous drip of oxytocin induced labor group ( control group) .Results The success rate of 24 h and 48 h to induced labor in A group was lower than that of control group, but B, C, D, E groups were higher than control group(P<0.05), no significant differences be-tween B, C, D, E groups( P>0.05); the rate of cesarean section in medicines groups were lower than that of control group, and the rate of viginal delivery were higher than that of control group ( P<0.05 ); the stages of labor in B, C, D, and E groups were significantly shorter than that of control group ( P <0.01 ); 48 h success rate of 25 μg induced labor was no difference between B and C groups ( P >0.05 ) . Conclusion Patients in B group had a high success rate of induced la-bor and high vaginal delivery rate, too low cesarean section rate and low rate of side effects such as contractions and amniotic fluid.Thus, 25 μg q6 h misoprostol is the recommended dose and method for patients.